Not Invented Here is Not an Option for Healthcare Information Technology Companies

As an M & A advisor, we regularly dialoguenew developments in this rapidly changing field
with the top executives in the industry. We havethrough internal development alone.
to chuckle when I reach a decision maker with aCisco seeks out investments in promising, small,
large HIT company and he says, "We have atechnology companies and this approach has been
corporate policy that we do not buy companies."a key element in their market dominance. They
Does this guy read the industry publications? Didbring what we refer to as smart money to the
he miss the latest HIMSS Conference? Things onhigh tech entrepreneur. They purchase a minority
the first floor of the San Diego Conventionstake in the early stage company with a call
Center were pretty much the same - the usualoption on acquiring the remainder at a later date
suspects. The convention, however, had grown towith an agreed-upon valuation multiple. This
1100 exhibitors and the overflow required almoststructure is a brilliantly elegant method to
the entire second floor.dramatically enhance the risk reward profile of
That was fun. What energy. It kind of remindednew product introduction. Here is why:
me of the old dot com days. Lots of money,For the Entrepreneur:
talent, ideas, hope, energy, and potential1. The involvement of Large HIT Investor -
successful businesses. This is the innovationresources, market presence, brand, distribution
environment in HIT and any large company thatcapability is a self fulfilling prophecy to your
feels it can keep pace with this force throughproduct's success. The halo of the big secure
internal development efforts alone is headedcompany helps you cross the chasm to the
down the path of extinction.conservative majority institutional customer.
Almost everyone will agree that information2. For the same level of dilution that an
technology will be a primary driver of controllingentrepreneur would get from a VC, angel investor
costs in the healthcare industry. There is,or private equity group, the entrepreneur gets
however, a huge paradox in this market. Thethe performance leverage of "smart money." See
institutional buyers of that technology are#1.
relatively conservative late adapters. This3. The entrepreneur gets to grow his business
prevents the expected innovation and commercialwith Large HIT Investor's support at a far more
success that should naturally follow the resourcesrapid pace than he could alone. He is more likely to
and passion of these HIMSS innovators.establish the critical mass needed for market
These entrepreneurs respond to a market needleadership within his industry's brief window of
and achieve encouraging initial success from theopportunity.
early adopters. They soon hit the wall and are not4. He gets an exit strategy with an established
able to "cross the chasm" from a small group ofvaluation metric while the buyer/investor helps
early adaptors to general market acceptancehim make his exit much more lucrative.
from the conservative majority. There is little5. As an old Wharton professor used to ask,
economic value created when good technology is"What would you rather have, all of a grape or
in the control or a failing company and thepart of a watermelon?" That sums it up pretty
technology never reaches broad acceptance.well. The involvement of Large HIT Investor gives
Most of the blockbuster new products are thethe product a much better probability of growing
result of an entrepreneurial effort from an earlysignificantly. The entrepreneur will own a
stage company bootstrapping its growth in a verymeaningful portion of a far bigger asset.
cost conscious lean environment. Think of someFor the Large HIT Investor:
of the new developments from PACS companies.1. Create access to a large funnel of developing
The big companies, with all their seemingtechnology and products.
advantages have a very high internal cost2. Creates a very nimble, market sensitive,
structure for new product introductions and theproduct development or R&D arm.
losses resulting from those failures are substantial.3. Minor resource allocation to the autonomous
Don't get me wrong, there were hundreds ofoperator during his "skunk works" market proving
failures from the start-ups as well. However, thedevelopment stage.
failure for the edgy little start-up resulted in losses4. Diversify their product development portfolio -
in the $1 - $5 million range. The same result frombecause this approach provides for a relatively
an industry giant were often in the $100 million tosmall investment in a greater number of
$250 million range.opportunities fueled by the entrepreneurial spirit,
For every IDX or eMerge there are literallythey greatly improve the probability of creating a
hundreds of companies that either flame out orwinner.
never reach a critical mass beyond a loyal early5. By investing early and getting an equity position
adapter market. It seems like the mentality ofin a small company and favorable valuation
these smaller business owners is, using themetrics on the call option, they pay a fraction of
example of the popular TV show, Deal or Nothe market price to what they would have to
Deal, to hold out for the $1 million briefcase. Whatpay if they acquired the company once the
about that logical contestant that objectivelyproduct had proven successful.
weighs the facts and the odds and cashes out forThese successful transactions can benefit the
$280,000?small entrepreneurial firm looking for the "smart
As we contemplated the dynamics of thismoney" investment with the appropriate growth
market, we were drawn to a merger andpartner. At the same time benefitting the large
acquisition model that is used in the networkingindustry player looking to enhance their new
technology market by Cisco Systems. We believeproduct strategy with this creative approach. This
that model could also be applied to greatmodel has successfully served the technology
advantage in the Healthcare Informationindustry through periods of outstanding growth
Technology industry. The giant networkingand market value creation. Many of the same
company, is a serial acquirer of companies. Theydynamics are present in the Healthcare
do a tremendous amount of R&D andInformation Technology industry and these same
organic product development. They recognize,transaction structures can be similarly employed
however, that they cannot possibly capture all theto create value.